tetraethylammonium has been researched along with Bright Disease in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Subsequent daily doses of gentamicin ranging from 0 to 120 mg/kg elicited a dose-response nephrotoxicity in both control and PVA-pretreated rats after 6 or 12 days of drug." | 1.27 | Dose-response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. II. Polyvinyl alcohol glomerulopathy. ( Brown, TT; Carver, MP; Monteiro-Riviere, NA; Riviere, JE, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carver, MP | 1 |
| Monteiro-Riviere, NA | 1 |
| Brown, TT | 1 |
| Riviere, JE | 1 |
1 other study available for tetraethylammonium and Bright Disease
| Article | Year |
|---|---|
Dose-response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. II. Polyvinyl alcohol glomerulopathy.
Topics: Animals; Carbon Radioisotopes; Gentamicins; Glomerular Mesangium; Glomerulonephritis; Half-Life; Inj | 1985 |